Table 2.
Adverse events (AEs) among participants with stroke (N = 10; total visits = 200)*.
| No. (%) of participants with AE | Total number of AEs | |
|---|---|---|
| All | 8 (80%) | 55 |
| Related to intervention | 5 (50%) | 18 |
| -Grade 1 (mild) | 4 (40%) | 15 |
| -Grade 2 (moderate) | 3 (30%) | 3 |
| -Grade 3–5 (severe-death) | 0 (0%) | 0 |
| -Cardiac disorder | 0 (0%) | 0 |
| -Soreness/pain | 4 (40%) | 10 |
| -Fatigue | 2 (20%) | 3 |
| -Nausea | 0 (0%) | 0 |
| -Lightheadedness | 2 (20%) | 5 |
| -Other nervous system | 0 (0%) | 0 |
| -Fall | 0 (0%) | 0 |
| -Other | 0 (0%) | 0 |
| Possibly related or unrelated to intervention | 8 (80%) | 37 |
| -Grade 1 (mild) | 8 (80%) | 34 |
| -Grade 2 (moderate) | 3 (30%) | 3 |
| -Grade 3–5 (severe-death) | 0 (0%) | 0 |
| -Cardiac disorder | 0 (0%) | 0 |
| -Soreness/pain | 7 (70%) | 14 |
| -Fatigue | 0 (0%) | 0 |
| -Nausea | 0 (0%) | 0 |
| -Lightheadedness | 3 (30%) | 6 |
| -Other nervous system | 0 (0%) | 0 |
| -Fall | 5 (50%) | 11 |
| -Headache | 2 (20%) | 2 |
| -Increased knee hyperextension | 1 (10%) | 1 |
| -Joint stiffness | 1 (10%) | 1 |
| -Infection (common cold) | 1 (10%) | 1 |
| -Excision of ingrown toenail | 1 (10%) | 1 |
| -Other | 0 (0%) | 0 |
*
There were no adverse events among control participants.